Navigation Links
Poll: 74% Support Banning Sale of Expired Baby Food, Formula and Over-the-Counter Meds
Date:9/28/2011

SACRAMENTO, Calif., Sept. 28, 2011 /PRNewswire-USNewswire/ -- 74% of California voters support legislation on Governor Jerry Brown's desk which would ban the sale of expired infant formula, baby food and over-the-counter medication, according to an opinion poll conducted from September 15 through September 18, 2011. Assembly Bill 688, by Assemblyman Richard Pan, won bipartisan support in the state legislature.

Fairbank, Maslin, Maullin, Metz and Associates polled 443 likely November 2012 voters. The Consumer Federation of California sponsored the poll.

The question posed was: "Recently, the California State Legislature passed a bill that prohibits grocery and drug stores from selling infant formula, baby food, and over-the-counter medications after the expiration date.  Do you support or oppose this bill?"

74% of voters surveyed support AB 688. 58% said they strongly support AB 688. Only 15% oppose the measure. 11% have no opinion. Support runs across the ideological spectrum.  74% of Republicans and 71% of Democrats support the measure. 69% of voters who identify themselves as conservatives, 76% of moderates, and 74% of liberals support the bill.

"Californians across the political spectrum support AB 688 because it is a common sense regulation that protects our families' health," stated Richard Holober, Executive Director of the Consumer Federation of California.

AB 688 fills a gap in the regulation of food and medications.  Federal regulations require expiration dates on labels of over-the-counter drugs, and "use by" dates on labels of infant formula and baby food, as the manufacturer's guarantee that the food will remain nutritional, and that the medication will remain safe and effective until that date.

Despite the federal requirement for these dates, there is no prohibition against retailers selling food and drugs after the guaranteed date of quality and effectiveness has expired.  AB 688 would correct this inconsistency, and prohibit supermarkets, drug stores and big box retailers from selling expired infant formula, baby food and over-the-counter medications.

Investigations by state agencies, consumer advocates and news reporters in California and other states have found repeated instances of sales of these expired products by large retail chains, including Wal-Mart, Toys "R" Us, Target, and Rite Aid pharmacy stores.

Governor Jerry Brown has until October 9 to sign or veto AB 688.

The non-profit Consumer Federation of California has advocated for consumer rights since 1960.


'/>"/>
SOURCE Consumer Federation of California
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Consumer Reports Flu Poll: Approximately Three Out of 10 Health Care Workers Living in a Bubble, Not Getting Flu Vaccine
2. New Poll: Voters Want to Reduce Wasteful Spending in Medicaid Pharmacy
3. Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs
4. New Study Supports Efficacy of Vagus Nerve Stimulation for Treatment-Resistant Depression
5. Cell Therapeutics, Inc. (CTI) Supports Panel Discussion on Women and Lung Cancer on Capitol Hill
6. EntreMed Raises $20 Million to Support Clinical Development Program
7. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
8. Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer
9. Isis Reports Preclinical Data Supporting Liver Safety of ISIS 301012
10. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
11. PositiveFriends.com Launches STD Social Networking Site Balancing Dating with Online Support Features
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... 2017  PhaseRx, Inc. (NASDAQ: PZRX), a biopharmaceutical ... diseases in children, today reported financial results for ... 31, 2016 and provided an update on its ... make progress during the fourth quarter of 2016 ... primate safety study, and with our lead development ...
(Date:3/24/2017)... , March 24, 2017 Abdominal Aortic Aneurysm Repair Devices ... by 2022, Globally, registering a CAGR of 5.1% from 2016 to 2022. The endovascular ... to dominate the market during the study period. Continue ... ... ...
(Date:3/24/2017)... , Mar. 24, 2017 Research ... Management in the U.S.: Consumer Strategies" report to their ... ... how adults approach and treat their physical pain, emphasizing consumer ... distinct groups: pain sufferers and adults who have selected illnesses/conditions ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... March 24, 2017 , ... ... contaminated soil, dredged material, and hazardous and non-hazardous materials announced today the acquisition ... This acquisition will add four additional processing facilities and a vast array ...
(Date:3/24/2017)... ... March 24, 2017 , ... The Radiology Business Management Association ... The annual awards, now in their 12th year, are among the most prestigious in ... In 2016, the awards were retooled to recognize achievements in both large budget (over ...
(Date:3/24/2017)... ... March 24, 2017 , ... Shamanic healer and teacher ... Healing and Spiritual Awakening, proudly presents her Sacred Peru retreat with world ... and spiritual journey during the Summer Solstice will also be her final international ...
(Date:3/24/2017)... ... ... The law firm of Enea, Scanlan & Sirignano, LLP, with ... C. Enea has joined the firm as an associate attorney. Ms. Enea, who previously ... law, Medicaid planning and applications, and Wills, Trusts and Estates. Samantha A. Lyons, ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Finding ... God #TruthwithGrace”: a devotional journal chronicling the writer’s path toward true communion with ... Walk with God #TruthwithGrace” is the creation of published author Lea Michelle Johnson, ...
Breaking Medicine News(10 mins):